您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
专利权人:
Alnylam Pharmaceuticals; Inc.
发明人:
Querbes, William,Fitzgerald, Kevin,Bettencourt, Brian,Liebow, Abigail,Erbe, David V.
申请号:
AU2015330726
公开号:
AU2015330726A1
申请日:
2015.10.09
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
The invention relates to RNAi agents, e.g. double-stranded RNAi agents, targeting the HAO1 gene, and methods of using such RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1. Described herein are double-stranded RNAi agents which inhibit the expression of a HA01 gene in a cell, such as a cell within a subject, e.g., a mammal, such as a human having a HAO1 associated disorder, and uses of such double-stranded RNAi agents. In certain aspects of the invention, substantially all of the nucleotides of an iRNA of the invention are modified.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充